Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 11:17 (2227 d 11:26 ago) – Posting: # 20128
Views: 4,273

❝ ❝ Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


❝ What does your protocol say on exactly that matter?


My protocol says within (-0.20 and 0.20)

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
91 visitors (0 registered, 91 guests [including 10 identified bots]).
Forum time: 22:44 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5